These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 2412976

  • 1. Selected immunologic properties of tiprinast, a non-steroidal antiallergy agent.
    Gillespie E, Dungan KW, Gomoll AW, Seidehamel RJ.
    Int J Immunopharmacol; 1985; 7(5):655-60. PubMed ID: 2412976
    [Abstract] [Full Text] [Related]

  • 2. Synthesis of 3,4-dihydro-4-oxothieno[2,3-d]pyrimidine-2-carboxylates, a new series of orally active antiallergy agents.
    Temple DL, Yevich JP, Covington RR, Hanning CA, Seidehamel RJ, Mackey HK, Bartek MJ.
    J Med Chem; 1979 May; 22(5):505-10. PubMed ID: 88521
    [Abstract] [Full Text] [Related]

  • 3. Studies on antiulcer agents. II. Antiulcer properties of N-(1H-tetrazol-5-yl)-2-anilino-5-pyrimidinecarboxamides inhibiting release of histamine from passively sensitized rat peritoneal mast cells.
    Terashima K, Tanimura T, Shimamura H, Kawase A, Uenishi K, Tanaka Y, Kimura I, Kamisaki T, Ishizuka Y, Sato M.
    Chem Pharm Bull (Tokyo); 1995 Jun; 43(6):1042-4. PubMed ID: 7543824
    [Abstract] [Full Text] [Related]

  • 4. REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
    Khandwala A, Coutts S, Pruss T, Jones H, Neiss E, Weinryb I.
    Biochem Pharmacol; 1987 Mar 01; 36(5):663-72. PubMed ID: 2435293
    [Abstract] [Full Text] [Related]

  • 5. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T, Yamamura H, Kohno S, Ohata K.
    Arerugi; 1992 Jun 01; 41(6):676-85. PubMed ID: 1280084
    [Abstract] [Full Text] [Related]

  • 6. Immunopharmacologic properties of WY-16, 922, a new orally effective antiallergic agent.
    Rosenthale ME, Begany AJ, Dervinis A, Sellstedt J, Guinosso C, Gluckman MI.
    J Pharmacol Exp Ther; 1976 Jun 01; 197(3):725-33. PubMed ID: 58988
    [Abstract] [Full Text] [Related]

  • 7. Antiallergic activity profiles in vitro of RHC 3164 and related compounds. II. Comparison of RHC 3164 with disodium cromoglycate.
    Khandwala A, Dally-Meade V, Jariwala N, Huang F.
    Int Arch Allergy Appl Immunol; 1984 Jun 01; 73(1):65-70. PubMed ID: 6198288
    [Abstract] [Full Text] [Related]

  • 8. 1,2,4-Triazolo[4,3-a]quinoxaline-1,4-diones as antiallergic agents.
    Loev B, Musser JH, Brown RE, Jones H, Kahen R, Huang FC, Khandwala A, Sonnino-Goldman P, Leibowitz MJ.
    J Med Chem; 1985 Mar 01; 28(3):363-6. PubMed ID: 2579236
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and antiallergic activities of 1,3-oxazolo[4,5-h]quinolines.
    Musser JH, Jones H, Sciortino S, Bailey K, Coutts SM, Khandwala A, Sonnino-Goldman P, Leibowitz M, Wolf P, Neiss ES.
    J Med Chem; 1985 Sep 01; 28(9):1255-9. PubMed ID: 2411926
    [Abstract] [Full Text] [Related]

  • 10. Effect of disodium cromoglycate on mast cell-mediated immediate-type allergic reactions.
    Shin HY, Kim JS, An NH, Park RK, Kim HM.
    Life Sci; 2004 Apr 23; 74(23):2877-87. PubMed ID: 15050425
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of allergic histamine release from rat peritoneal mast cells by azelastine. Interaction with selected antiasthmatic drugs.
    Chand N, Pillar J, Diamantis W, Sofia RD.
    Int Arch Allergy Appl Immunol; 1988 Apr 23; 86(3):256-60. PubMed ID: 2456990
    [Abstract] [Full Text] [Related]

  • 12. Antiallergic activity of tiaramide (RHC 2592-A).
    Khandwala A, Coutts S, Weinryb I.
    Int Arch Allergy Appl Immunol; 1982 Apr 23; 69(2):159-68. PubMed ID: 6179887
    [Abstract] [Full Text] [Related]

  • 13. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J, Duval D, Prouteau M, Voltz C, Berry CN, Lloyd KG, Scatton B.
    Arzneimittelforschung; 1995 May 23; 45(5):559-68. PubMed ID: 7541995
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
    Butchers PR, Fullarton JR, Skidmore IF, Thompson LE, Vardey CJ, Wheeldon A.
    Br J Pharmacol; 1979 Sep 23; 67(1):23-32. PubMed ID: 115530
    [Abstract] [Full Text] [Related]

  • 15. Antiallergic action of disodium cromoglycate and xanthone RS 7540.
    Gonzalez Alvarez R, Kazimierczak W.
    Arch Immunol Ther Exp (Warsz); 1982 Sep 23; 30(5-6):333-9. PubMed ID: 6135406
    [Abstract] [Full Text] [Related]

  • 16. Indolo[2,1-c][1,4]benzodiazepines: a new class of antiallergic agents.
    Ho CY, Hageman WE, Persico FJ.
    J Med Chem; 1986 Jun 23; 29(6):1118-21. PubMed ID: 2872333
    [Abstract] [Full Text] [Related]

  • 17. Enhancement by reproterol of the ability of disodium cromoglycate to stabilize rat mastocytes.
    Eleno N, Gajate E, Macias J, Garay RP.
    Pulm Pharmacol Ther; 1999 Jun 23; 12(1):55-60. PubMed ID: 10208836
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. RHC 3024: antiallergic activity in vitro and comparison with disodium cromoglycate and other antiallergic agents.
    Khandwala A, Coutts SM, Dally-Meade V, Jariwala N, Huang FC.
    Int Arch Allergy Appl Immunol; 1983 Jun 23; 70(4):311-20. PubMed ID: 6186610
    [Abstract] [Full Text] [Related]

  • 20. Antiallergic activity of alkyl substituted pyrazolo[3, 4-d]pyrimidine (compound 88-765).
    Gupta PP, Srimal RC, Avasthi K, Garg N, Chandra T, Bhakuni DS.
    Indian J Exp Biol; 1995 Jan 23; 33(1):38-40. PubMed ID: 9135673
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.